Petros Pharmaceuticals Inc (PTPI) — Capital Reinvestment Ratio
Petros Pharmaceuticals Inc (PTPI) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow ($965.40K) in capital expenditures ($5.45K). See PTPI equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Petros Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2019)
This chart tracks Petros Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Check Petros Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Petros Pharmaceuticals Inc (2018–2019)
Year-by-year Capital Reinvestment Ratio for Petros Pharmaceuticals Inc from 2018 to 2019. For live market cap and broader valuation context, see Petros Pharmaceuticals Inc (PTPI) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | $2.53 Million | $71.54K | ▼ -87.9% |
| 2018 | 0.23x | $8.02 Million | $1.88 Million | — |